Skip to main content
OpenTrials
Completed

NCT Number: NCT01178437

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

The aim of the study is to prove the feasibility and safety of transcutaneous, electrical stimulation of the vagus nerve in patients with difficult-to-treat forms of epilepsy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Epilepsiezentrum Erlangen

Erlangen, Bavaria, 91054, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written Informed Consent
  • Patients of both gender, aged from 18-75 years
  • Diagnosis of epilepsy according to the diagnosis criteria of the DSM IV/ ICD 10 (especially G 40.1 /G 40.2/ G 40.3)
  • Insufficient response to at least one attempt of treatment in medical history with anticonvulsive medication, dosed sufficiently long and high
  • Antiepileptic Drugs (AED) therapy must be stable at a level that promises long-term continuity for at least 10 before study start and has to be continued for at least 3 months during treatment phase

Exclusion criteria

  • Absence of Informed Consent
  • Pregnancy
  • Psychiatric diseases, especially post-traumatic stress disorder, obsessive-compulsive disorders, schizophrenia, Borderline personality disorders (BPD), character disorders as well as major depressive disorders, anxiety disorders and eating disorders as comorbidity.
  • Abuse of drugs and alcohol until 12 weeks before study start
  • Cerebrovascular diseases
  • Dementia
  • Severe traumatic brain injury in medical history including invasive and non-invasive methods of therapy (tumor surgery, "Gamma Knife Surgery")
  • Indications of structural impairment of the basal ganglia or the brain stem
  • active implants (e.g. cochlea implants, VNS, pacemaker)
  • Severe neurological diseases (e.g. Morbus Parkinson, systemic neurologic diseases
  • severe internistic diseases (e.g. arterial hypertension, respiratory failure)
  • Bronchial asthma
  • malignant diseases of any kind, within five years before study start
  • Severe active infectious diseases (e.g. HIV, hepatitis)
  • Bone diseases (e.g. Morbus Paget, recent fractures)
  • Diseases of the ENT body system: Hearing loss of the left ear which is treated with a hearing instrument, all dermatologic and infectious diseases which affect the area around the pinna and the ear canal, severe malformation of the pinna
  • Vagotomy
  • Concurrent participation in other studies
  • Other circumstances that in the opinion of the investigator might be an obstacle for enrolling the subject

Treatment and study plan

T-VNS® Stimulator cM02 (Transcutaneous Stimulation of the Vagus Nerve)

Device

daily, transcutaneous, electrical stimulation of the vagus nerve by the t-VNS device for a period of 9 months

Other names: T-VNS® Stimulator cM02

Primary outcomes

  1. Assessment of performance

    Time frame: 9 months

    rated by investigator

    QOLIE-89 MADRS CCTE

Secondary outcomes

  1. Patient's subjective assessment of epileptic shocks

    Time frame: 9 months

    rated by patient. Subjective assessment of epileptic shocks and cognitive functions. Measured with "Erlanger Kognitionstest" (EKT)

  2. Further assessment of performance

    Time frame: 9 months

    EEG long-term monitoring, MR spectroscopy

  3. Assessment of Safety

    Time frame: 9 months

    Registration of (S)AEs and drop outs

Sponsors and collaborators

Lead sponsor

cerbomed GmbH

Industry

Registry information

Official study title

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy - a Prospective Pilot Study Regarding Safety, Effectiveness and Clinical Performance

Important dates

Study start
2009
Primary completion
2010
Study completion
2011
First posted
Aug 10, 2010
Registry last updated
Mar 8, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.